Investigational Drug Information for Talaporfin
✉ Email this page to a colleague
What is the drug development status for Talaporfin?
Talaporfin is an investigational drug.
There have been 12 clinical trials for Talaporfin.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2007.
The most common disease conditions in clinical trials are Liver Neoplasms, Prostatic Hyperplasia, and Neoplasms, Second Primary. The leading clinical trial sponsors are Light Sciences Oncology, Light Sciences LLC, and United States Department of Defense.
Summary for Talaporfin
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 1,499 |
WIPO Patent Applications | 988 |
Japanese Patent Applications | 129 |
Clinical Trial Progress | Phase 3 (2007-02-01) |
Vendors | 34 |
Recent Clinical Trials for Talaporfin
Title | Sponsor | Phase |
---|---|---|
A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia | Mundipharma Research Limited | Phase 2 |
A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia | Light Sciences Oncology | Phase 2 |
Novel Treatment for Port Wine Stain Birthmarks | Beckman Laser Institute University of California Irvine | Phase 1 |
Clinical Trial Summary for Talaporfin
Top disease conditions for Talaporfin
Top clinical trial sponsors for Talaporfin
US Patents for Talaporfin
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |